Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2023 Feb 24;36(3):168-175.
doi: 10.1093/ajh/hpac128.

Blood Pressure Variability and Cognitive Decline: A Post Hoc Analysis of the SPRINT MIND Trial

Isabel J Sible  1 , Daniel A Nation  2   3
Affiliations
Clinical Trial

Blood Pressure Variability and Cognitive Decline: A Post Hoc Analysis of the SPRINT MIND Trial

Isabel J Sible et al. Am J Hypertens. .

Abstract

Background: Blood pressure (BP) variability (BPV) is an emerging risk factor for cognitive impairment and dementia, but relationships with cognition in the context of antihypertensive strategies remain unclear. We examined whether visit-to-visit BPV relates to cognitive change based on antihypertensive treatment type.

Methods: In this post hoc analysis of the SPRINT MIND trial, 2,348 participants underwent 4 BP measurements over a 9-month period after treatment randomization (standard vs. intensive BP lowering) and ≥ 1 neuropsychological evaluation thereafter. BPV was calculated as tertiles of BP SD. Participants underwent cognitive testing at baseline and every 2 years during the planned 4-year follow-up. Cognitive composite scores were calculated for global cognition, memory, language, executive function, and processing speed. Linear mixed models investigated relationships between BPV, antihypertensive treatment group, and time on cognitive composite scores.

Results: Elevated BPV was associated with the fastest decline in processing speed (ß = -.07 [95% CI -.12, -.01]; P = 0.02) and executive function (ß = -.08 [95% CI -.16, -.006]; P = 0.03) in the standard treatment group only. BPV was not related to cognitive change in the intensive treatment group. Mean/minimum/maximum BP was not associated with cognitive composite scores over time in either antihypertensive treatment group.

Conclusions: Elevated BPV remains a risk for cognitive decline despite strictly controlled BP levels, in the standard treatment group. Specific declines were observed in processing speed and executive function, domains often impacted by cerebrovascular disease and may underpin risk for dementia and cerebrovascular disease associated with BPV. Clinical trial information: ClinicalTrials.gov; NCT01206062.

Keywords: antihypertensives; blood pressure variability; cognition; executive functioning; processing speed.

PubMed Disclaimer

Figures

Graphical Abstract
Graphical Abstract
Figure 1
Figure 1
| Elevated BPV is associated with processing speed and executive function decline in standard treatment group only. Conditional effects of BPV by time by antihypertensive treatment group on (A) standardized processing speed composite score and (B) standardized executive function composite score. Lines represent rate of change for each tertile of BPV (blue = 1st tertile of BPV; orange = 2nd tertile of BPV; green = 3rd tertile of BPV). Models adjusted for age, sex, race/ethnicity, education, adjudicated clinical diagnosis, history of cardiovascular disease, and mean BP. BPV, blood pressure variability.
See this image and copyright information in PMC

References

    1. Yaffe K. Prevention of cognitive impairment with intensive systolic blood pressure control. JAMA 2019; 321:548–549. - PubMed
    1. Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer’s disease prevalence. Lancet Neurol 2011; 10:819–828. doi:10.1016/S1474-4422(11)70072-2. - DOI - PMC - PubMed
    1. Williamson JD, Pajewski NM, Auchus AP, Bryan RN, Chelune G, Cheung AK, Cleveland ML, Coker LH, Crowe MG, Cushman WC, Cutler JA, Davatzikos C, Desiderio L, Erus G, Fine LJ, Gaussoin SA, Harris D, Hsieh M-K, Johnson KC, Kimmel PL, Tamura MK, Launer LJ, Lerner AJ, Lewis CE, Martindale-Adams J, Moy CS, Nasrallah IM, Nichols LO, Oparil S, Ogrocki PK, Rahman M, Rapp SR, Reboussin DM, Rocco MV, Sachs BC, Sink KM, Still CH, Supiano MA, Snyder JK, Wadley VG, Walker J, Weiner DE, Whelton PK, Wilson VM, Woolard N, Wright JTJ, Wright CB; SPRINT MIND Investigators for the SPRINT Research Group. Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial. JAMA 2019; 321:553–561. doi:10.1001/jama.2018.21442. - DOI - PMC - PubMed
    1. Group TSMI for the SR. Association of intensive vs standard blood pressure control with cerebral white matter lesions. JAMA 2019; 322:524–534. doi:10.1001/jama.2019.10551. - DOI - PMC - PubMed
    1. de Heus RAA, Tzourio C, Lee EJL, Opozda M, Vincent AD, Anstey KJ, Hofman A, Kario K, Lattanzi S, Launer LJ, Ma Y, Mahajan R, Mooijaart SP, Nagai M, Peters R, Turnbull D, Yano Y, Claassen JAHR, Tully PJ; VARIABLE BRAIN Consortium. Association between blood pressure variability with dementia and cognitive impairment: a systematic review and meta-analysis. Hypertension 2021; 78:1478–1489. doi:10.1161/HYPERTENSIONAHA.121.17797. - DOI - PMC - PubMed

Publication types

Substances

Associated data